Robinson C - Search Results

1

Localised spontaneous regression in mesothelioma -- possible immunological mechanism.

Robinson BW, Robinson C, Lake RA. Robinson BW, et al. Among authors: robinson c. Lung Cancer. 2001 May;32(2):197-201. doi: 10.1016/s0169-5002(00)00217-8. Lung Cancer. 2001. PMID: 11325491

2

Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group.

Armato SG 3rd, Coolen J, Nowak AK, Robinson C, Gill RR, Straus C, Khanwalkar A. Armato SG 3rd, et al. Among authors: robinson c. Lung Cancer. 2015 Nov;90(2):148-54. doi: 10.1016/j.lungcan.2015.07.011. Epub 2015 Jul 29. Lung Cancer. 2015. PMID: 26298162 Review.

3

Effect of NSAIDS and COX-2 inhibitors on the incidence and severity of asbestos-induced malignant mesothelioma: evidence from an animal model and a human cohort.

Robinson C, Alfonso H, Woo S, Olsen N, Bill Musk AW, Robinson BW, Nowak AK, Lake RA. Robinson C, et al. Among authors: robinson bw. Lung Cancer. 2014 Oct;86(1):29-34. doi: 10.1016/j.lungcan.2014.08.005. Epub 2014 Aug 18. Lung Cancer. 2014. PMID: 25175318

4

Statins do not alter the incidence of mesothelioma in asbestos exposed mice or humans.

Robinson C, Alfonso H, Woo S, Walsh A, Olsen N, Musk AW, Robinson BW, Nowak AK, Lake RA. Robinson C, et al. Among authors: robinson bw. PLoS One. 2014 Aug 5;9(8):e103025. doi: 10.1371/journal.pone.0103025. eCollection 2014. PLoS One. 2014. PMID: 25093718 Free PMC article.

5

MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma.

Robinson C, Walsh A, Larma I, O'Halloran S, Nowak AK, Lake RA. Robinson C, et al. Eur J Cancer. 2011 Jan;47(1):151-61. doi: 10.1016/j.ejca.2010.08.015. Epub 2010 Sep 16. Eur J Cancer. 2011. PMID: 20850297

6

Antitumor efficacy of the novel chemotherapeutic agent coramsine is potentiated by cotreatment with CpG-containing oligodeoxynucleotides.

van der Most RG, Himbeck R, Aarons S, Carter SJ, Larma I, Robinson C, Currie A, Lake RA. van der Most RG, et al. Among authors: robinson c. J Immunother. 2006 Mar-Apr;29(2):134-42. doi: 10.1097/01.cji.0000187958.38179.a9. J Immunother. 2006. PMID: 16531814

7

A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent.

Robinson C, van Bruggen I, Segal A, Dunham M, Sherwood A, Koentgen F, Robinson BW, Lake RA. Robinson C, et al. Among authors: robinson bw. Cancer Res. 2006 Nov 15;66(22):10786-94. doi: 10.1158/0008-5472.CAN-05-4668. Cancer Res. 2006. PMID: 17108115

8

Consistent gene expression profiles in MexTAg transgenic mouse and wild type mouse asbestos-induced mesothelioma.

Robinson C, Dick IM, Wise MJ, Holloway A, Diyagama D, Robinson BW, Creaney J, Lake RA. Robinson C, et al. Among authors: robinson bw. BMC Cancer. 2015 Dec 18;15:983. doi: 10.1186/s12885-015-1953-y. BMC Cancer. 2015. PMID: 26680231 Free PMC article.

9

Dietary vitamin D supplementation does not reduce the incidence or severity of asbestos-induced mesothelioma in a mouse model.

Robinson C, Woo S, Nowak AK, Lake RA. Robinson C, et al. Nutr Cancer. 2014;66(3):383-7. doi: 10.1080/01635581.2013.878733. Epub 2014 Feb 24. Nutr Cancer. 2014. PMID: 24564337

10

The antioxidants vitamins A and E and selenium do not reduce the incidence of asbestos-induced disease in a mouse model of mesothelioma.

Robinson C, Woo S, Walsh A, Nowak AK, Lake RA. Robinson C, et al. Nutr Cancer. 2012;64(2):315-22. doi: 10.1080/01635581.2012.649100. Epub 2012 Jan 31. Nutr Cancer. 2012. PMID: 22292488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results